StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Prabhudas Lilladher

BUYRainbow Childrens Medicare Limited

byPrabhudas LilladherHorizon: NA (inferred 1 year)26 May 2025via Institutional / Brokerage Research

Entry₹1,357.5Inferred
Target₹1,725
Total upside +27.07% (call closed)
Stop lossNot given
At expiry₹1,365.426 May 2026, 3:30 pm
Expired+0.58%
Follow Prabhudas Lilladher for new calls(67% target hit, 415 closed calls)Get alertsWatch RAINBOW for new buy/sell callsGet alertsSee 6 active Long-term calls on RAINBOWSee 108 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 9 Sept, 6:42 pm IST
2 supporting2 neutral1 opposing
Supports the BUY call (2)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·26 May · today

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·30 Jan · 4mo ago

Neutral / worth noting (2)

Press Release on the Audited Finacial Results (Standalone & Consolidated) for the quarter and Financial Year Ended March 31, 2026.

BSE · Company Update·23 May · 2d ago

(opens in new tab)

Outcome of Board Meeting for declaring the financial results (Standalone & Consolidated) for the financial year ended March 31, 2026.

BSE · Board Meeting·23 May · 2d ago

(opens in new tab)
Weighs against the BUY call (1)

Rainbow Children's Medicare Limited's appeal against a GST demand notice has been disallowed, upholding the original order. The company is considering a further appeal.

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·8 May · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.